This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_COLON_ADENO_EXALLC for full statistics.
Colon adenocarcinoma
C3_COLON_ADENO
colon adenocarcinoma: An adenocarcinoma arising from the colon. It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease. Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits. According to the degree of cellular differentiation, colonic adenocarcinomas are divided into well, moderately, and poorly differentiated. Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
4617 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
4617 |
4. Check minimum number of eventsNone |
4617 |
5. Include endpoints |
4617 |
6. Filter based on genotype QC (FinnGen only) |
4617 |
Control definitions (FinnGen only)
- Control conditions
- not HLP_C3_COLON_ADENO
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Colon adenocarcinoma
based on the number of shared cases.
Similar with more cases:
- Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of colon
- Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)
- Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)
- Colorectal adenocarcinoma
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4617 | 1984 | 2633 |
| Unadjusted period prevalence (%) | 0.95 | 0.68 | 1.16 |
| Median age at first event (years) | 70.09 | 69.28 | 70.70 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4303
- Matched controls
- 43027
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.8
323.3
696
827
WX302
NOMESCO Finland
Thoracal epidural anesthesy
11.0
323.0
906
1022
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
3635.8
323.0
346
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
159.7
323.0
628
46
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
6.3
323.0
1021
2013
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
115.9
323.0
899
98
A04AA02
ATC
granisetron; systemic, transdermal
10.4
323.0
988
1193
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
193.9
323.0
818
52
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
9162.5
323.0
768
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
216.1
323.0
393
20
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
26.6
323.0
555
238
JN4BD
NOMESCO Finland
Extensive body CT
7.2
323.0
1488
2935
B01AB05
ATC
enoxaparin; parenteral
4.0
323.0
2313
9610
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
323.0
1427
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
169.8
323.0
344
22
UJF32
NOMESCO Finland
Coloscopy
10.1
323.0
3003
7983
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
323.0
683
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
160.5
323.0
922
73
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
16.8
323.0
587
401
A03FA01
ATC
metoclopramide; systemic, rectal
5.8
323.0
1973
5482
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
130.6
323.0
597
53
130
Kela drug reimbursment
Malignant tumour
17.0
323.0
2060
2207
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
258.0
323.0
782
37
H02AB02
ATC
dexamethasone; systemic
5.8
323.0
1099
2408
L01BC06
ATC
capecitabine; oral
42.1
323.0
1569
579
JFB30
NOMESCO Finland
Right hemicolectomy
69.3
323.0
897
163
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
6062.6
323.0
543
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
268.8
323.0
1311
70
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
158.8
321.1
337
23
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
17.0
315.5
519
344
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
10.3
297.6
621
691
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
162.3
288.0
302
20
JFB46
NOMESCO Finland
Resection of sigmoid colon
25.3
276.0
395
171
JN4AD
NOMESCO Finland
Body CT examination
5.7
275.0
885
1866
C18.31
ICD-10 Finland
Malignant tumor of flexura hepatica invasive carcinoma
205.6
261.8
270
14
WZC30
NOMESCO Finland
Teaching
4.3
251.1
1104
3214
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
14.0
243.2
433
342
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
23.9
241.4
351
159
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
110.2
238.1
259
25
JFB43
NOMESCO Finland
Left hemicolectomy
41.6
237.0
299
77
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.1
230.2
688
1302
TPH07
NOMESCO Finland
Cathetrisation of artery
4.3
226.4
968
2712
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
89.3
226.2
252
30
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
242.8
225.2
230
10
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
223.5
1669
7313
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
152.5
218.9
231
16
C18.0
ICD-10 Finland
Malignant neoplasm: Caecum
159.7
215.9
227
15
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
131.8
210.5
225
18
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.5
199.6
563
978
C18.2
ICD-10 Finland
Malignant neoplasm: Ascending colon
215.1
199.1
205
10
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
102.8
196.1
215
22
D75
ICPC
Malignant neoplasm colon/rectum
32.1
194.3
260
86
C18.30
ICD-10 Finland
Malignant tumor of flexura hepatica without histology
163.8
193.4
203
13
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
71.3
189.1
217
32
C18.51
ICD-10 Finland
Malignant tumor of flexura hiealis invasive carcinoma
334.4
188.9
190
6
8140/3-C18.3
ICD-O-3
Adenocarcinoma, NOS, of hepatic flexure of colon
+∞
184.7
176
*
8140/3-C18.6
ICD-O-3
Adenocarcinoma, NOS, of descending colon
1838.7
175.1
169
*
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
5.1
170.0
587
1291
C18.02
ICD-10 Finland
Malignant tumor of caecum carcinoma of adenoma
290.8
164.9
167
6
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.7
161.5
438
713
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
160.4
1018
3818
C18.60
ICD-10 Finland
Malignant tumor of the descending colon without histology
188.1
156.9
163
9
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.2
156.0
653
1739
C18.22
ICD-10 Finland
Malignant tumor of the colon ascending carcinoma of the adenoma
234.2
154.2
158
7
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.5
150.0
414
688
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
7.1
145.5
377
573
B01AB10
ATC
tinzaparin; parenteral
4.3
144.5
596
1558
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.8
144.2
441
835
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.0
137.0
404
730
JN4CD
NOMESCO Finland
Very extensive body CT
5.3
136.6
447
915
C18.50
ICD-10 Finland
Malignant tumor in flexural lienalis without histology
206.6
135.6
140
7
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
5.2
132.3
441
921
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
11.8
130.8
249
222
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
129.7
755
2618
D64.9
ICD-10 Finland
Anaemia, unspecified
3.0
126.4
841
3197
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.9
124.8
330
514
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
117.6
1578
8816
C18
ICD-10 Finland
Malignant neoplasm of colon
205.6
116.2
120
6
8140/3-C18.5
ICD-O-3
Adenocarcinoma, NOS, of splenic flexure of colon
+∞
111.9
107
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
8.7
109.9
247
299
C18.91
ICD-10 Finland
Malignant tumor of unspecified location in colon invasive carcinoma
75.2
109.0
124
17
Z51.5
ICD-10 Finland
Palliative care
3.5
106.4
542
1679
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
18.4
106.1
167
94
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
25.0
96.9
138
57
ZX120
NOMESCO Finland
Intravenous
3.0
96.4
629
2323
C18.9
ICD-10 Finland
Malignant neoplasm: Colon, unspecified
147.7
95.5
101
7
L01BC59
ATC
trifluridine, combinations; systemic
65.7
94.1
109
17
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
10.9
93.0
183
174
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
72.3
92.8
106
15
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
64.5
92.1
107
17
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
7.2
91.9
232
336
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
63.9
91.1
106
17
JAH00
NOMESCO Finland
Laparotomy
5.5
88.1
277
535
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
87.6
442
1348
176
Kela drug reimbursment
Regorafenib
61.4
87.2
102
17
WX402
NOMESCO Finland
General anaesthesia
2.5
84.8
772
3459
UJF30
NOMESCO Finland
Ileoscopy through colon
2.9
84.0
561
2092
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
25.5
82.8
117
47
JFB54
NOMESCO Finland
Laparoscopic resection of sigmoid colon with partial proctectomy
61.3
82.1
96
16
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
51.1
78.8
95
19
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
14.8
78.6
134
93
369
Kela drug reimbursment
Regorafenib
48.5
78.1
95
20
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
76.5
495
1802
C18.4
ICD-10 Finland
Malignant neoplasm: Transverse colon
137.5
76.2
81
6
JFH00
NOMESCO Finland
Total colectomy and ileorectal anastomosis
44.2
73.5
91
21
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
12.0
73.1
137
118
C18.49
ICD-10 Finland
Malignant tumor of the transverse colon other or unspecified histology
720.1
72.3
71
*
JJB10
NOMESCO Finland
Atypcal resection of liver
38.7
71.6
91
24
C18.39
ICD-10 Finland
Malignant tumor of flexura hepatica other or unspecified histology
152.6
71.2
75
5
1XC07
NOMESCO Finland
NA
37.1
70.9
91
25
JFB50
NOMESCO Finland
Other resection of colon
32.0
70.8
94
30
A04AA01
ATC
ondansetron; systemic, rectal
3.2
70.6
406
1360
JFB00
NOMESCO Finland
Partial resection of small intestine
6.8
70.3
185
284
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
4.3
67.9
268
656
N02BE01
ATC
paracetamol; systemic, rectal
2.0
66.3
3645
31491
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.1
66.1
391
1333
N02AA05
ATC
oxycodone; systemic
2.1
66.0
882
4690
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
65.9
1047
5976
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
4.9
64.6
221
468
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
64.2
1421
9126
C18.42
ICD-10 Finland
Malignant tumor of the transverse colon carcinoma of the adenoma
138.1
64.0
68
5
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
6.0
63.3
181
310
C18.62
ICD-10 Finland
Malignant tumor of the descending colon carcinoma of the adenoma
316.5
62.5
63
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
7.1
61.9
157
229
C18.6
ICD-10 Finland
Malignant neoplasm: Descending colon
+∞
61.6
59
*
JFB40
NOMESCO Finland
Resection of transverse colon
36.5
61.5
79
22
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
60.4
1654
11317
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
4.5
59.7
221
508
C18.3
ICD-10 Finland
Malignant neoplasm: Hepatic flexure
206.2
59.2
61
*
A02BC02
ATC
pantoprazole; systemic
1.7
59.1
2790
22340
6404
FHL
Hemicolectomy on the right
58.4
58.7
69
12
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
3.4
57.3
303
950
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
22.6
56.2
82
37
Z31.5
ICD-10 Finland
Genetic counselling
4.6
55.6
203
460
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
10.7
55.4
109
104
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.1
54.8
179
360
A04AD12
ATC
aprepitant; systemic
6.0
54.7
156
267
L01XE21
ATC
[U] regorafenib; oral
50.7
54.1
65
13
K56.7
ICD-10 Finland
Ileus, unspecified
5.5
53.6
164
306
C18.32
ICD-10 Finland
Malignant tumor of flexura hepatica carcinoma of adenoma
+∞
53.2
51
*
JAH01
NOMESCO Finland
Laparoscopy
3.9
53.0
229
608
C18.69
ICD-10 Finland
Malignant tumor of colon descendens other or unspecified histology
524.2
52.6
52
*
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.5
52.2
261
783
C18.59
ICD-10 Finland
Malignant tumor in flexura lienalis other or unspecified histology
139.2
51.9
55
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
51.6
1385
9299
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.2
51.0
291
964
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
5.1
50.0
163
327
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.9
48.4
313
1127
E0000UV
ATC
NA
1.7
48.2
1571
11097
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
47.1
2006
15177
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
34.3
47.0
61
18
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
46.7
847
4982
8140/3-C18.1
ICD-O-3
Adenocarcinoma, NOS, of appendix
+∞
45.9
44
*
C18.1
ICD-10 Finland
Malignant neoplasm: Appendix
161.7
45.9
48
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
5.8
45.5
133
235
UJF34
NOMESCO Finland
Left colonoscopy
10.1
45.0
91
92
8140/3-C18.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of colon
+∞
44.9
43
*
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
26.9
44.2
61
23
C18.5
ICD-10 Finland
Malignant neoplasm: Splenic flexure
97.1
43.8
48
5
JFF10
NOMESCO Finland
Loop enterostomy
10.3
43.0
86
85
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
151.5
42.8
45
*
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
8.7
42.3
93
109
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
42.1
425
1961
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.8
41.9
123
219
WX704
NOMESCO Finland
Intubation
2.5
41.8
343
1421
ZXD05
NOMESCO Finland
Urgent procedure
1.6
41.5
1323
9192
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.7
41.4
298
1147
B01AB04
ATC
dalteparin; parenteral
2.7
40.2
301
1184
C18.81
ICD-10 Finland
Malignant overall tumor of the colon invasive carcinoma
401.2
40.2
40
*
JKA20
NOMESCO Finland
Cholecystectomy
3.4
40.1
208
642
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.3
40.0
125
240
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.4
39.8
201
607
A04AA55
ATC
palonosetron, combinations; systemic
4.3
39.5
153
368
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
5.2
39.0
124
243
Z93.3
ICD-10 Finland
Colostomy status
7.8
38.8
91
119
JFF23
NOMESCO Finland
Transversostomy
5.6
37.3
111
201
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
6.7
37.1
96
145
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
18.6
37.0
57
31
WW500
NOMESCO Finland
Blood transfusion
2.9
36.8
242
878
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.2
36.6
144
352
JFF13
NOMESCO Finland
Terminal enterostomy
22.3
36.5
53
24
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
9.4
36.4
76
82
V03AF03
ATC
calcium folinate; systemic
19.2
36.1
55
29
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
8.3
36.1
81
99
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
16.3
35.9
58
36
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
3.3
35.7
186
576
K92.1
ICD-10 Finland
Melaena
2.4
34.8
322
1418
C18.12
ICD-10 Finland
Malignant tumor of the appendix carcinoma of the adenoma
124.4
34.7
37
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.3
34.1
183
579
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
13.2
34.1
60
46
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
34.1
585
3340
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
42.3
34.0
42
10
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
33.6
474
2519
C18.52
ICD-10 Finland
Malignant tumor of flexura lienalis carcinoma of adenoma
+∞
33.4
32
*
L01BC53
ATC
tegafur, combinations; systemic
28.4
33.3
45
16
1533A
ICD-9 Finland
Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,INVASIIVINEN KARSINOOMA]
329.6
32.9
33
*
JJB71
NOMESCO Finland
Laparoscopic resection of liver
29.6
32.9
44
15
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
6.0
32.8
93
159
1534A
ICD-9 Finland
Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,INVASIIVINEN KARSINOOMA]
+∞
32.3
31
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
2.9
31.0
201
725
TJF80
NOMESCO Finland
Ostomy education
5.8
30.3
87
152
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
68.4
29.9
34
5
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
29.6
746
4790
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.8
29.3
127
340
JFB51
NOMESCO Finland
Other laparoscopic resection of colon
80.7
28.8
32
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.7
28.6
202
766
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.1
28.5
79
132
JFA42
NOMESCO Finland
Endoscopic injection in colon
9.6
28.3
58
61
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.8
28.1
81
142
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
31.1
28.1
37
12
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
6.6
27.8
72
110
C18.80
ICD-10 Finland
Malignant overall tumor of the colon without histology
78.1
27.8
31
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.8
27.6
94
200
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
4.3
27.5
105
251
TJX00
NOMESCO Finland
Punkture or biopsy in gastrointestinal endoscopy
26.6
27.0
37
14
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.7
26.9
119
325
JFG36
NOMESCO Finland
Closure of terminal colostomy with anastomosis to rectum
27.9
26.6
36
13
3AC01
NOMESCO Finland
NA
5.6
26.6
79
144
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.3
26.5
135
412
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
26.1
560
3418
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
9.9
25.9
52
53
JAL30
NOMESCO Finland
Omentectomy
5.8
25.9
74
129
Z85.0
ICD-10 Finland
Personal history of malignant neoplasm of digestive organs
13.6
24.9
43
32
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
14.1
24.8
42
30
TPX15
NOMESCO Finland
Removal of vascular injection port
9.1
24.7
52
58
D01.0
ICD-10 Finland
Carcinoma in situ: Colon
90.6
24.7
27
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
24.5
1549
12186
JFC10
NOMESCO Finland
Ileotransversostomy
34.7
24.2
31
9
WX110
NOMESCO Finland
Local anesthesy
1.4
24.2
2357
20017
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
24.0
290
1441
1536A
ICD-9 Finland
Malignant neoplasm of colon, Ascending colon[NEOPL MALIG COLI ASCENDENTIS,INVASIIVINEN KARSINOOM]
+∞
24.0
23
*
K65.0
ICD-10 Finland
Acute peritonitis
4.4
23.8
87
200
1XC08
NOMESCO Finland
NA
241.2
23.7
24
*
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
125.7
23.6
25
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.1
23.5
269
1307
KCD10
NOMESCO Finland
Partial cystectomy
33.5
23.3
30
9
D77
ICPC
Malignant digestive neopl other/NOS
9.3
23.2
48
52
B80
ICPC
Iron deficiency anaemia
3.5
23.2
109
314
UJG02
NOMESCO Finland
Proctoscopy
3.2
23.0
122
385
JJB30
NOMESCO Finland
Excision of two segments of liver
24.8
23.0
32
13
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
7.8
23.0
53
69
R4110
NOMESCO Finland
Physiotherapy
1.5
21.6
1037
7695
Z93.2
ICD-10 Finland
Ileostomy status
11.9
21.5
39
33
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
4.7
21.4
73
157
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.6
21.0
158
626
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
5.0
20.9
68
139
JFH10
NOMESCO Finland
Total colectomy and ileostomy
16.6
20.9
33
20
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.1
20.9
243
1190
SPAT1125
SPAT
Stoma care and guidance
3.2
20.7
110
349
WX002
NOMESCO Finland
Sedation and analgesia
1.5
20.6
810
5752
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
20.6
239
1169
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
7.0
20.6
51
74
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
6.9
20.4
51
75
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
20.2
338
1901
SPAT1131
SPAT
Colonoscopy
2.5
19.9
160
655
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
14.4
19.8
33
23
JJB20
NOMESCO Finland
Excision of single segment of liver
35.9
19.8
25
7
R50.9
ICD-10 Finland
Fever, unspecified
1.6
19.8
545
3553
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
4.3
19.7
74
176
SPAT1153
SPAT
Removal of sutures
1.4
19.3
1294
10176
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.3
19.2
184
826
WX600
NOMESCO Finland
Single shot through catheter
4.8
19.0
63
132
A79
ICPC
Malignancy NOS
3.4
18.9
93
279
WX725
NOMESCO Finland
Noninvasive ventilation
2.2
18.8
195
908
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
4.5
18.7
67
152
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
17.2
18.7
29
17
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
4.3
18.3
68
160
D99
ICPC
Disease digestive system other
4.7
17.9
61
132
S18
ICPC
Laceration/cut
1.3
17.8
1659
13717
LAE10
NOMESCO Finland
Unilateral oophorectomy
11.9
17.8
32
27
D50
ICD-10 Finland
Iron deficiency anaemia
3.5
17.3
81
235
ZX121
NOMESCO Finland
Central venous catheter
9.8
17.1
34
35
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.8
16.9
112
410
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
6.3
16.8
44
70
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
16.3
16.5
26
16
15302
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Cacci
170.6
16.5
17
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
16.5
315
1849
JFB63
NOMESCO Finland
Other resection of colon with proximal colostomy and closure of distal stump
27.6
16.5
22
8
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
2.9
16.4
100
350
6434
FHL
Anterior resection
9.8
16.1
32
33
WX882
NOMESCO Finland
High dependency care
2.5
16.1
130
538
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
16.0
407
2593
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
15.6
120
482
JJB53
NOMESCO Finland
Excision of segments IV,V, VI, VII and VIII of liver
160.5
15.5
16
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
13.8
15.5
26
19
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.4
15.3
75
226
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
15.0
760
5640
JFH96
NOMESCO Finland
Other total colectomy
31.8
14.8
19
6
Z3231
NOMESCO Finland
Registered nurse
1.4
14.7
1044
8219
JFB20
NOMESCO Finland
Ileocaecal resection
6.7
14.5
36
54
R11
ICD-10 Finland
Nausea and vomiting
1.7
14.4
294
1759
L03AA02
ATC
filgrastim; parenteral
2.4
14.4
121
510
XX3DW
NOMESCO Finland
Time consuming IT work
1.6
14.3
389
2524
B82
ICPC
Anaemia other/unspecified
2.4
14.1
120
509
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.5
13.8
106
428
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
13.5
213
1177
K56.0
ICD-10 Finland
Paralytic ileus
3.2
13.5
69
216
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
3.3
13.5
66
200
JFF30
NOMESCO Finland
Other colostomy
16.2
13.4
21
13
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
9.4
13.4
27
29
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
13.4
380
2489
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
13.2
544
3876
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
6.3
13.2
34
54
R4190
NOMESCO Finland
Nutritional therapy
2.4
12.9
110
469
D64.8
ICD-10 Finland
Other specified anaemias
2.7
12.9
87
327
L01BC04
ATC
carmofur; oral
19.1
12.9
19
10
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
50.1
12.8
15
*
L01EX05
ATC
regorafenib; oral
50.1
12.8
15
*
L03AA13
ATC
pegfilgrastim; parenteral
2.2
12.8
135
635
WX290
NOMESCO Finland
Other blockade of nerve
1.3
12.8
1113
9000
XQ902
NOMESCO Finland
Other photography
5.0
12.7
40
81
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.6
12.7
91
353
J01MA12
ATC
levofloxacin; systemic
1.4
12.2
750
5743
QX9VV
NOMESCO Finland
NA
37.6
12.2
15
*
D50.8
ICD-10 Finland
Other iron deficiency anaemias
3.0
12.1
67
223
JJA20
NOMESCO Finland
Open biopsy of liver
7.8
12.1
27
35
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.8
11.8
191
1066
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
14.7
11.8
19
13
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.1
11.7
135
663
JAQ10
NOMESCO Finland
Intraoperative hypertermic chemotherapeutic perfusion of abdominal cavity
65.1
11.6
13
*
JFC20
NOMESCO Finland
Other enterocolostomy
19.0
11.6
17
9
1531A
ICD-9 Finland
Malignant neoplasm of colon, Transverse colon[NEOPL MALIG COLI TRANSV,INVASIIVINEN KARSINOOMA]
+∞
11.5
11
*
15311
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Transverse colon, including hepatic and splenic flexures
+∞
11.5
11
*
JJA40
NOMESCO Finland
Excision of lesion of liver
+∞
11.5
11
*
Z3226
NOMESCO Finland
Physiotherapist
1.4
11.4
668
5070
Z43.3
ICD-10 Finland
Attention to colostomy
7.5
11.4
26
35
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
11.3
290
1852
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.9
11.3
165
887
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
11.3
291
1863
C18.82
ICD-10 Finland
Malignant overall tumor of colon carcinoma of adenoma
35.1
11.3
14
*
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
4.8
11.3
36
75
JFA70
NOMESCO Finland
Suture of small intestine
6.5
11.2
28
43
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
3.8
11.1
46
123
A06AH03
ATC
naloxegol; oral
3.2
11.0
56
177
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.5
10.9
81
323
C18.89
ICD-10 Finland
Malignant overall tumor of the colon other or unspecified histology
43.4
10.9
13
*
ZX100
NOMESCO Finland
Oral
2.7
10.9
72
267
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.7
10.8
226
1367
JFG29
NOMESCO Finland
Closure of terminal enterostomy with anastomosis to rectum
17.8
10.7
16
9
SPAT1255
SPAT
Intravenous administration of medicine
1.6
10.6
256
1610
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.6
10.6
46
128
C18.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of colon
60.1
10.6
12
*
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
3.1
10.5
57
188
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
3.4
10.4
49
146
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
10.4
140
733
JF2BD
NOMESCO Finland
Extensive colon CT
3.2
10.2
51
159
SPAT1109
SPAT
Analgesia with portable analgesic pump
3.7
10.1
42
113
K63.5
ICD-10 Finland
Polyp of colon
2.9
10.0
59
206
JFB96
NOMESCO Finland
Other partial excision of intestine
14.6
10.0
16
11
ZXC40
NOMESCO Finland
Use of ultrasound
4.3
10.0
35
81
SPAT1262
SPAT
Handing over of treatment supplies
1.3
9.6
710
5582
NK6LA
NOMESCO Finland
Bone and joint kinetic X-ray examination
11.4
9.5
17
15
JFF26
NOMESCO Finland
Sigmoidostomy
8.4
9.5
20
24
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
6.3
9.5
24
38
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.7
9.5
195
1174
JMA10
NOMESCO Finland
Transabdominal total splenectomy
4.4
9.5
33
76
3049
Kela drug reimbursment
NA
100.2
9.4
10
*
JFB41
NOMESCO Finland
Laparoscopic resection of transverse colon
30.1
9.4
12
*
JFH01
NOMESCO Finland
Laparoscopic colectomy with ileorectal anastomosis
30.1
9.4
12
*
1534X
ICD-9 Finland
Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,EI HISTOLOGISTA VAHVISTUSTA]
+∞
9.4
9
*
WX004
NOMESCO Finland
Patient-controlled sedation
4.7
9.3
30
64
TJG20
NOMESCO Finland
Transanal irrigation
7.7
9.1
20
26
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
3.2
9.0
46
147
1XA03
NOMESCO Finland
NA
36.8
9.0
11
*
JJA43
NOMESCO Finland
Destruction of lesion of liver
36.8
9.0
11
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.7
9.0
493
6372
6406
FHL
Other column resection
9.0
9.0
18
20
R18
ICD-10 Finland
Ascites
2.3
8.9
78
341
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
3.2
8.9
44
137
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
6.5
8.9
22
34
Y83.2
ICD-10 Finland
Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.5
8.9
22
34
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
6.3
8.8
22
35
6405
FHL
Hemicolectomy on the left
9.5
8.8
17
18
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
4.6
8.8
29
64
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
14.0
8.7
14
10
6407
FHL
Colectomy and ileorectostomy
50.1
8.7
10
*
UJK02
NOMESCO Finland
ERCP
2.0
8.6
107
545
R03AC02
ATC
salbutamol; inhalant
0.8
8.4
1335
15262
JAD10
NOMESCO Finland
Repair of incisional hernia
3.1
8.4
43
139
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
6.7
8.3
20
30
1532A
ICD-9 Finland
Malignant neoplasm of colon, Descending colon[NEOPL MALIG COLI DESCEND,INVASIIVINEN KARSINOOMA]
+∞
8.3
8
*
1533X
ICD-9 Finland
Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,EI HISTOLOGISTA VAHVISTUSTA]
+∞
8.3
8
*
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
5.0
8.3
25
50
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
2.0
8.3
104
531
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
5.5
8.3
23
42
D16
ICPC
Rectal bleeding
2.2
8.3
78
353
M25.5
ICD-10 Finland
Pain in joint
0.8
8.2
534
6750
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
2.9
8.2
47
162
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.7
8.1
148
863
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
6.0
8.1
21
35
JFW98
NOMESCO Finland
Other transluminal endoscopic operation on intestine
33.4
8.1
10
*
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
8.0
84
399
JWE00
NOMESCO Finland
Reoperation for deep haemorrhage in gastroenterological surgery
5.0
8.0
24
48
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
5.0
8.0
24
48
ZX050
NOMESCO Finland
Stereotactic radiotherapy
3.3
7.9
38
117
WW200
SPAT
NA
0.6
7.9
117
1925
Z43.2
ICD-10 Finland
Attention to ileostomy
6.6
7.9
19
29
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
3.3
7.8
37
113
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
4.6
7.8
25
54
WX892
NOMESCO Finland
Monitored bed care
1.5
7.8
284
1973
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
7.8
389
2869
JFA68
NOMESCO Finland
Endoscopic insertion of prosthetic tube into colon
45.0
7.7
9
*
D07AA02
ATC
hydrocortisone; topical
1.4
7.7
387
2857
N02AX02
ATC
tramadol; systemic, rectal
1.2
7.6
1578
13961
JFB21
NOMESCO Finland
Laparoscopic ileocaecal resection
6.7
7.6
18
27
WB600
NOMESCO Finland
Neoadjuvant therapy of primary tumour with antibodies
25.0
7.6
10
*
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
2.6
7.5
52
202
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
7.5
502
3880
Z93
ICD-10 Finland
Artificial opening status
4.8
7.4
23
48
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
6.4
7.4
18
28
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
4.3
7.3
25
58
15303
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Coli ascendentis
+∞
7.3
7
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.0
7.3
86
432
K59.09
ICD-10 Finland
Constipation, unspecified
1.5
7.3
230
1547
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
6.8
7.3
17
25
KCH00
NOMESCO Finland
Suture of bladder
6.2
7.2
18
29
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.3
7.2
16
22
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
7.2
571
4525
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
1.9
7.2
94
493
K83.1
ICD-10 Finland
Obstruction of bile duct
2.4
7.1
55
229
8240/3-C18.1
ICD-O-3
Neuroendocrine tumor, NOS, of appendix
12.0
7.1
12
10
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
2.9
7.1
39
134
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.4
7.0
56
235
WGA11
NOMESCO Finland
Planning of pain management
8.8
7.0
14
16
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
2.5
7.0
51
206
M02AA07
ATC
piroxicam; topical
0.8
7.0
1047
12091
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
7.0
7.0
16
23
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.1
7.0
*
258
D06BX01
ATC
metronidazole; topical
1.4
7.0
296
2122
Z2221
NOMESCO Finland
Medical doctor
1.2
6.9
917
7733
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
6.3
6.9
17
27
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.4
6.9
55
232
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
3.6
6.9
29
82
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
3.3
6.8
32
98
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
4.2
6.8
24
58
XX_20
NOMESCO Finland
Bioimpedance measurement
9.3
6.8
13
14
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
6.7
684
5591
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
2.3
6.7
58
256
A06AD11
ATC
lactulose; oral
1.3
6.7
628
5082
TQW40
NOMESCO Finland
Remowal of suture of skin
1.5
6.7
210
1411
SPAT1078
SPAT
Removal of central venous or arterial cannula
7.2
6.7
15
21
P01AB01
ATC
metronidazole; oral, rectal
1.2
6.7
1227
10697
K63.9
ICD-10 Finland
Disease of intestine, unspecified
3.8
6.6
26
69
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
3.1
6.6
33
106
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
7.8
6.6
14
18
RD211
NOMESCO Finland
NA
1.7
6.6
140
856
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
5.5
6.6
18
33
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
3.2
6.6
32
101
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.1
6.6
72
353
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
2.3
6.6
57
253
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
6.5
208
1406
K35.1
ICD-10 Finland
Acute appendicitis with peritoneal abscess
2.8
6.5
39
141
TJA10
NOMESCO Finland
Laparocentesis
4.8
6.5
20
42
N05AX08
ATC
risperidone; systemic
0.6
6.5
132
2021
K62.1
ICD-10 Finland
Rectal polyp
2.5
6.5
46
182
D01
ICPC
Abdominal pain/cramps general
1.4
6.5
277
1986
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.7
6.5
120
708
WZA10
NOMESCO Finland
Long statement of health and health related matters
2.6
6.4
44
173
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.3
6.4
53
231
Z2446
NOMESCO Finland
Social worker
1.5
6.3
183
1213
JAA10
NOMESCO Finland
Excision of lesion of abdominal wall
11.0
6.3
11
10
Z12.1
ICD-10 Finland
Special screening examination for neoplasm of intestinal tract
3.6
6.3
26
73
15331
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Sigmoid colon
26.7
6.2
8
*
1BC02
NOMESCO Finland
NA
26.7
6.2
8
*
N81.6
ICD-10 Finland
Rectocele
0.6
6.2
75
1293
TJX90
NOMESCO Finland
Other minor procedure in gastroenterological surgery
6.3
6.2
15
24
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.1
6.1
68
333
JG1BG
NOMESCO Finland
MRI of rectum
3.0
6.1
32
107
JFA52
NOMESCO Finland
Other endoscopic haemostatic procedure in colon
4.0
6.1
22
55
J01.0
ICD-10 Finland
Acute maxillary sinusitis
0.7
6.1
302
3964
JFG30
NOMESCO Finland
Closure of colostomy with resection of exteriorised loop
6.7
6.0
14
21
JAK03
NOMESCO Finland
Laparotomy and peritoneal irrigation
6.7
6.0
14
21
LCD00
NOMESCO Finland
Hysterectomy
1.7
6.0
119
713
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
545
866
7.00
307.65
5.6
2.9
u/ml
238.3
870.4
1.18
501
793
(3022145) Colonoscopy Study observation
1593
3839
5.81
307.65
1.5
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
3380
4225
27.13
307.65
9.4
3.4
ug/l
31.2
21.4
1.01
3131
3458
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
1005
1478
8.41
307.65
6.0
3.0
u/ml
2050.1
3673.5
0.36
894
1260
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1073
3752
3.42
243.37
2.6
2.1
g/l
0.2
0.2
0.33
1029
3459
(4035726)
995
3379
3.48
235.77
1.4
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3144
20288
2.72
215.34
14.6
6.0
umol/l
11.9
12.3
0.67
3065
19187
(3024561) Albumin [Mass/volume] in Serum or Plasma
2865
17720
2.63
213.28
9.6
4.7
g/l
33.4
34.6
21.77
2748
16281
(3044640) Blood type and Crossmatch panel - Blood
2219
12272
2.56
207.60
3.2
2.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2814
17420
2.58
206.36
5.4
4.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1327
6148
2.63
174.05
2.2
2.5
g/l
2.5
2.3
26.09
1270
5645
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1270
5794
2.64
171.56
2.2
2.6
%
17.7
21.8
21.59
1122
4861
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1763
9404
2.42
169.98
3.0
2.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1378
6613
2.54
166.92
2.2
2.5
umol/l
10.6
12.2
11.05
1308
6070
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1910
10703
2.34
162.81
2.4
2.3
mg/l
4.3
3.0
36.69
1677
9025
(3037121) Protein [Mass/volume] in Urine
465
1405
3.57
128.00
6.0
2.9
g/l
0.2
0.3
8.41
357
538
(40768804) Tissue Pathology biopsy report
2262
14555
2.09
126.86
2.7
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1971
12277
2.06
118.32
4.9
4.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1640
9641
2.09
114.31
5.5
4.0
%
85.5
84.4
0.91
1617
9403
(3013650) Neutrophils [#/volume] in Blood by Automated count
2914
21053
2.04
113.49
16.2
8.6
e9/l
3.9
4.3
14.04
2645
18177
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2207
14494
2.00
112.47
3.0
2.9
ug/l
116.8
158.0
9.71
2031
13058
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
233
463
5.25
111.06
2.2
2.1
u/ml
411.1
1047.0
0.45
228
453
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1927
12149
2.01
109.49
3.0
2.6
u/l
54.1
58.6
3.49
1827
11123
(3032080) INR in Blood by Coagulation assay
2515
17692
1.93
100.54
10.3
11.1
inr
1.3
1.4
3.35
660
4746
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
854
4215
2.26
90.19
3.4
2.6
umol/l
10.4
9.5
0.38
774
3675
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3589
29083
2.05
87.58
15.9
7.6
u/l
93.7
81.2
18.52
3472
27169
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
675
3136
2.35
81.59
1.6
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1296
7991
1.86
71.84
9.4
3.0
mmol/l
2.5
2.5
3.85
1214
6928
(3013826) Glucose [Moles/volume] in Serum or Plasma
2972
23306
1.77
71.67
6.0
4.8
mmol/l
6.9
6.9
0.24
2858
21934
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2678
20657
1.71
65.75
8.1
6.8
mmol/l
1.2
1.2
13.65
2281
17296
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1102
6632
1.87
64.94
4.9
3.0
mmol/l
0.8
0.8
4.31
1052
6113
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2457
18724
1.67
61.30
7.1
6.0
mmol/l
1.2
1.2
8.50
2280
16766
(3002173) Hemoglobin [Mass/volume] in Arterial blood
764
4226
1.97
57.37
7.8
7.2
g/l
114.4
120.2
13.70
744
4064
(3015377) Calcium [Moles/volume] in Serum or Plasma
1902
13748
1.65
56.92
8.1
3.3
mmol/l
2.3
2.4
0.34
1726
11675
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
657
3455
2.05
56.86
2.8
2.4
u/l
39.8
39.3
0.03
592
2925
(3016502) Oxygen saturation in Arterial blood
819
4662
1.92
56.40
7.5
6.7
%
96.6
95.3
7.19
799
4467
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
500
2384
2.23
55.70
8.4
9.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
44
24
18.50
55.18
1.0
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
381
1643
2.44
53.49
2.5
2.8
u/ml
0.3
0.3
0.45
231
943
(3003396) Base excess in Arterial blood by calculation
869
5169
1.84
51.72
7.2
6.5
mmol/l
0.6
1.1
2.55
688
3965
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1567
11008
1.64
51.04
5.0
3.1
u/l
42.5
37.9
0.30
1500
10361
(3027801) Oxygen [Partial pressure] in Arterial blood
866
5186
1.82
50.28
7.2
6.5
kpa
13.6
11.9
15.33
835
4913
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
866
5187
1.82
50.24
7.3
6.5
kpa
5.1
5.1
0.24
837
4912
(3014576) Chloride [Moles/volume] in Serum or Plasma
905
5534
1.79
48.86
8.1
6.2
mmol/l
105.2
104.3
6.50
884
5396
(40768441) Liver Pathology biopsy report
106
221
4.89
47.70
1.1
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
697
3964
1.89
47.44
5.7
6.6
mmol/l
9.7
11.2
6.12
662
3738
(40758558) Short blood count panel - Blood
1346
9247
1.64
47.11
12.7
6.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
670
3843
1.87
44.18
6.1
6.1
mmol/l
1.3
1.4
1.27
636
3681
(3027945) Reticulocytes/100 erythrocytes in Blood
865
5404
1.74
42.73
1.9
2.4
%
1.8
1.8
0.63
759
4716
(3003694) ABO and Rh group [Type] in Blood
1263
8751
1.61
41.76
1.3
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
510
2758
1.95
39.99
8.4
7.9
%
94.7
93.7
2.96
510
2745
(3000991) Gas panel - Venous blood
614
3594
1.82
37.52
7.1
7.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
868
5733
1.63
33.90
2.2
2.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
2154
17327
1.46
33.19
5.1
6.0
%
23.8
26.1
15.67
1998
15905
(3019069) Monocytes/100 leukocytes in Blood
2123
17038
1.46
33.08
5.1
6.2
%
9.0
8.9
0.45
1978
15744
(3006504) Eosinophils/100 leukocytes in Blood
2113
16964
1.45
32.73
4.9
5.9
%
2.7
2.8
2.04
1966
15629
(40768797) Stomach Pathology biopsy report
779
5103
1.63
31.19
1.2
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
2054
16522
1.44
30.84
5.0
5.9
%
0.6
0.7
7.48
1910
15239
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
288
1389
2.14
30.72
1.3
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
2215
18105
1.43
30.23
4.6
5.5
e9/l
0.0
0.0
3.69
1889
15370
(3031040) Bacteria [#/volume] in Urine by Automated count
2949
25390
1.45
30.22
4.9
5.1
e6/l
1353.2
2350.5
0.37
37
434
(42870588) Differential panel, method unspecified - Blood
1650
12844
1.44
29.09
4.6
5.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
2238
18407
1.42
29.05
4.8
5.6
e9/l
1.8
1.9
0.32
1948
15873
(3018010) Neutrophils/100 leukocytes in Blood
2099
17081
1.42
28.87
5.0
5.8
%
60.4
58.6
8.53
1963
15761
(3001604) Monocytes [#/volume] in Blood
2193
17992
1.42
28.76
4.6
5.5
e9/l
0.6
0.6
0.53
1866
15249
(3003458) Phosphate [Moles/volume] in Serum or Plasma
813
5479
1.59
28.72
4.7
5.5
mmol/l
1.0
1.0
0.33
755
5018
(3013115) Eosinophils [#/volume] in Blood
2260
18674
1.41
28.27
4.8
5.7
e9/l
0.2
0.2
1.69
1952
16077
(3002582) Erythrocytes [#/volume] in Urine
1606
12512
1.43
27.88
3.5
3.5
e6/l
50.0
99.2
2.10
1299
9758
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2489
20954
1.41
27.72
3.9
3.2
u/l
74.8
56.4
7.39
2329
18949
(3026782) Osmolality of Urine
1135
8346
1.48
26.45
3.0
2.9
mosm/kgh2o
548.1
550.5
0.13
1000
7089
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
408
2340
1.82
26.26
8.3
8.1
mmol/l
23.8
24.3
2.05
396
2153
(3002256) Pathology report gross observation
741
4987
1.58
26.10
1.4
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
632
4107
1.62
25.75
1.9
2.4
e9/l
70.9
68.1
1.02
494
3124
(3019060) Gas panel - Arterial blood
498
3059
1.70
25.21
5.6
4.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
212
993
2.19
24.33
7.5
7.0
mmol/l
106.2
105.1
2.80
195
883
(3039000) Anion gap in Blood
212
993
2.19
24.33
7.5
7.0
mmol/l
11.1
11.2
0.07
195
883
(3019309) Folate [Moles/volume] in Red Blood Cells
1198
9086
1.43
23.19
1.8
1.8
nmol/l
1192.2
1163.9
0.44
915
6723
(3030467) Casts [#/volume] in Urine by Automated count
1452
11405
1.40
22.97
3.4
3.4
e6/l
0.5
0.5
0.22
1158
8717
(36304419) Bacteria [Presence] in Urine
1397
10922
1.40
22.64
3.4
3.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
466
2891
1.68
22.64
7.9
6.5
mmol/l
24.1
24.5
1.43
444
2692
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
392
2322
1.75
22.53
2.6
2.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
338
1937
1.80
21.74
1.9
1.9
ug/l
1.5
2.4
1.29
306
1663
(3018418) pH of Serum or Plasma
1533
12250
1.38
21.52
4.7
4.0
ph
7.4
7.4
2.11
323
2284
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
112
420
2.71
20.98
1.2
1.1
g/l
1.6
1.6
0.26
107
369
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3809
35231
1.46
20.65
28.3
17.4
mg/l
36.7
26.9
48.83
3535
28869
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
731
5158
1.50
20.29
2.9
4.0
u/l
244.4
246.5
0.14
693
4828
(3047181) Lactate [Moles/volume] in Blood
254
1371
1.90
19.76
6.9
6.2
mmol/l
1.4
1.3
0.75
230
1213
(3018095) Leukocytes [#/volume] in Urine
1719
14147
1.34
19.43
4.0
4.0
e6/l
102.8
116.2
0.32
1350
10371
(3007930) Methemoglobin/Hemoglobin.total in Blood
325
1905
1.76
19.34
6.0
5.2
%
0.9
0.9
0.68
305
1788
(3026008) Bacteria identified in Urine by Culture
1597
13011
1.35
19.26
3.4
3.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
310
1802
1.77
18.98
1.2
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1142
8867
1.38
18.59
2.8
2.7
e6/l
5.2
4.9
0.41
1022
7767
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
324
1929
1.73
18.24
5.9
5.1
%
1.6
1.6
0.15
306
1808
(3037467) Urinalysis macro (dipstick) panel - Urine
2892
25782
1.33
18.11
5.4
4.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
258
1464
1.81
17.13
2.6
3.9
u/ml
73.5
75.0
0.03
251
1400
(3019225) pH of Specimen
616
4350
1.48
16.81
4.9
4.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
868
6591
1.39
15.83
2.0
2.0
s
30.2
30.1
0.09
849
6373
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
126
575
2.22
15.52
6.0
6.4
mg/l
11.9
12.4
0.74
116
525
(40762365) Oxygen content in Arterial blood by calculation
34
73
4.68
14.91
2.7
3.4
ml/dl
13.6
15.0
2.27
34
67
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
171
890
1.96
14.87
1.8
2.3
%
223.9
201.8
2.67
163
843
(3021447) Carbon dioxide [Partial pressure] in Venous blood
583
4186
1.45
14.49
3.1
3.5
kpa
5.6
5.8
7.69
565
4046
(3002032) Base excess in Venous blood by calculation
580
4175
1.45
14.21
3.1
3.5
mmol/l
1.6
2.0
1.29
445
3362
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
115
526
2.22
14.12
1.3
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
343
2215
1.59
14.07
1.4
1.7
g/l
1.7
1.6
3.26
295
1881
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
176
951
1.88
13.71
1.8
2.1
%
82.1
88.8
3.13
169
904
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
851
6601
1.35
13.35
3.1
3.2
e6/l
3.1
2.1
2.14
509
3730
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
111
516
2.18
13.12
1.3
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
161
872
1.88
12.48
1.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
109
516
2.14
12.33
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
109
517
2.14
12.27
1.3
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
109
518
2.13
12.22
1.3
1.4
—
—
—
0
0
(4281824)
83
355
2.36
11.98
1.1
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
109
523
2.11
11.93
1.3
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
918
7338
1.31
11.54
1.8
1.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
379
2621
1.49
11.36
1.5
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1978
17414
1.24
11.03
2.1
2.1
pmol/l
89.1
93.1
3.26
1143
9004
(3007566) Smooth muscle Ab [Titer] in Serum
152
845
1.83
10.89
1.3
1.1
titre
60.0
93.1
1.52
12
54
(3019550) Sodium [Moles/volume] in Serum or Plasma
3904
37163
1.33
10.60
33.9
20.7
mmol/l
139.3
139.6
9.17
3840
36130
(40761511) CBC panel - Blood by Automated count
3775
35771
1.30
10.59
28.8
16.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
3906
37228
1.32
10.18
34.0
20.9
mmol/l
4.0
4.0
6.56
3838
36135
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
34
98
3.49
10.15
1.9
2.4
—
—
—
0
0
(3013512) EKG study
1425
12207
1.24
9.95
4.6
4.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
300
2036
1.51
9.87
2.9
3.6
mmol/l
23.5
24.1
2.17
272
1807
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
193
1182
1.66
9.86
1.7
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
283
1912
1.51
9.52
1.9
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
166
996
1.69
9.19
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
167
1005
1.69
9.15
1.1
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
38
128
2.99
8.87
1.5
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
808
6554
1.28
8.87
26.8
29.5
inr
1.4
1.5
1.07
131
903
(3052851) Hemolysis interference index of Serum or Plasma
196
1241
1.61
8.81
4.8
3.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
166
1010
1.67
8.74
1.1
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
260
1765
1.50
8.57
1.8
1.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
458
3456
1.36
8.40
2.7
3.0
kpa
4.6
4.5
0.64
441
3328
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
178
1122
1.61
8.17
1.5
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
778
9433
0.79
8.10
1.7
1.6
mmol/l
1.4
1.3
2.04
643
7776
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
418
3128
1.37
8.08
4.0
2.8
ml/min/173m2
61.7
60.6
0.25
198
1353
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
853
7039
1.26
8.06
3.0
3.0
e6/l
1.3
1.2
0.14
506
4129
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
557
4358
1.32
7.99
4.8
3.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
143
860
1.68
7.90
2.2
2.6
umol/l
30.1
34.6
1.73
120
700
(3020891) Body temperature
259
1794
1.47
7.75
5.1
4.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1805
16137
1.19
7.67
4.2
4.2
ng/l
46.3
92.9
0.98
1480
12483
(3007853) Bacteria identified in Skin by Aerobe culture
573
4527
1.30
7.64
1.8
1.8
—
—
—
0
0
(3036489) Thrombin time
193
1264
1.55
7.55
1.8
1.9
s
21.9
21.7
0.27
181
1145
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
993
8410
1.23
7.35
3.9
4.1
ng/l
520.8
492.3
0.04
852
7280
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
450
3484
1.32
6.95
4.5
3.9
mmol/l
1.2
1.2
0.39
409
3030
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3851
37013
1.24
6.88
19.1
11.3
u/l
24.9
25.2
0.49
3764
35322
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3463
32932
1.21
6.86
29.0
16.6
ml/min/173m2
74.6
72.7
6.30
3123
27352
(3021589) Normoblasts [#/volume] in Blood
1749
15730
1.18
6.66
14.5
10.3
e9/l
0.0
0.0
0.82
1416
12761
(40760892) CBC W Ordered Manual Differential panel - Blood
850
7166
1.23
6.50
3.8
4.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3195
30217
1.19
6.49
30.9
18.9
%
36.7
38.5
15.08
1965
18611
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
48
217
2.22
6.28
2.2
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
189
1286
1.49
6.24
1.1
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
148
978
1.53
5.65
4.6
4.8
mmol/l
2.7
2.7
0.07
106
672
(3044889) 12 lead EKG panel
2772
26068
1.16
5.50
4.5
4.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
62
326
1.91
5.48
1.2
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1178
10390
1.18
5.44
1.6
1.6
nmol/l
20.9
20.2
0.68
1001
8761
(3043409) Potassium [Moles/volume] in Arterial blood
194
1368
1.44
5.38
5.1
3.8
mmol/l
3.8
3.9
3.72
183
1270
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
67
364
1.85
5.37
1.3
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
429
5329
0.79
5.32
1.3
1.3
iu/ml
47.1
37.7
0.67
141
1637
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
13
31
4.20
5.08
1.2
1.5
%
22.9
15.8
—
7
18
(3027273) Bicarbonate [Moles/volume] in Venous blood
296
2264
1.33
5.02
3.2
3.4
mmol/l
24.5
25.2
3.02
287
2193
(3004119) Hemoglobin [Mass/volume] in Venous blood
351
2754
1.30
4.96
2.8
3.2
g/l
121.0
127.3
5.22
339
2680
(3010421) pH of Blood
164
1140
1.45
4.94
4.5
4.6
ph
7.4
7.4
0.23
145
955
(3024731) MCV [Entitic volume]
3926
38075
1.21
4.91
44.0
25.4
fl
91.1
91.8
12.56
3876
37290
(3026361) Erythrocytes [#/volume] in Blood
3926
38077
1.21
4.90
44.1
25.5
e12/l
4.3
4.4
52.62
3843
36674
(3007461) Platelets [#/volume] in Blood
3925
38072
1.21
4.86
44.2
25.5
e9/l
248.7
240.2
10.59
3853
36838
(3002385) Erythrocyte distribution width [Ratio]
2935
27832
1.15
4.85
37.0
21.2
%
14.8
13.9
112.19
2899
27098
(3035941) MCH [Entitic mass]
3925
38075
1.21
4.84
44.0
25.4
pg
30.0
30.5
35.76
3874
37292
(3000963) Hemoglobin [Mass/volume] in Blood
3926
38086
1.21
4.83
44.4
25.6
g/l
126.3
133.0
124.70
3877
37316
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
406
5018
0.79
4.82
1.2
1.2
u/ml
22.4
13.9
0.84
154
1747
(3010813) Leukocytes [#/volume] in Blood
3925
38086
1.20
4.76
44.2
25.5
e9/l
7.0
6.9
1.82
3849
36679
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
59
321
1.85
4.75
1.3
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
73
426
1.73
4.66
2.9
3.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
743
6386
1.19
4.56
1.2
1.2
u/ml
1.2
1.7
0.87
181
1565
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
896
7832
1.18
4.52
1.7
1.7
mg/l
1.8
1.5
1.71
727
6108
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
46
236
1.96
4.43
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
46
236
1.96
4.43
1.3
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
73
438
1.68
4.25
4.6
3.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
54
935
0.57
4.12
1.3
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3238
33635
0.88
4.08
4.3
4.7
mmol/l
1.4
1.4
1.08
2861
30114
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1527
13974
1.14
4.07
3.0
3.2
ng/l
1871.1
1820.9
0.12
1319
12129
(3017181) Myelocytes/100 leukocytes in Blood
397
3243
1.25
4.06
3.2
4.0
%
1.0
1.0
0.04
146
974
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3196
33220
0.88
4.04
6.7
6.6
mmol/mol
41.5
41.0
1.98
2868
30088
(3051651) Icteric interference index of Serum or Plasma
45
240
1.88
3.91
5.8
3.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3276
33975
0.88
3.91
4.3
4.8
mmol/l
4.4
4.5
1.26
2928
30671
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
354
2875
1.25
3.83
1.3
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
376
3076
1.24
3.81
3.2
4.0
%
0.2
0.1
0.18
137
908
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1023
9149
1.15
3.79
1.7
1.7
pmol/l
419.8
25887583.2
5.59
834
7355
(1616796) Gas panel - Central venous blood
140
999
1.41
3.75
3.8
4.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
58
340
1.71
3.72
2.8
3.8
u/ml
56.0
45.9
0.12
58
335
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
137
976
1.42
3.71
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
137
976
1.42
3.71
1.3
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
159
2147
0.73
3.70
2.4
2.4
au/ml
17.0
23.5
—
6
66
(3019977) pH of Arterial blood
47
260
1.82
3.67
3.6
2.5
ph
7.4
7.4
1.12
16
93
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
141
1934
0.72
3.62
1.3
1.3
au/ml
49.8
58.7
—
8
80
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
591
5080
1.19
3.62
1.8
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
499
4225
1.20
3.61
1.4
1.4
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
18
68
2.65
3.56
2.5
2.7
u/l
68.7
42.3
—
7
21
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
102
693
1.48
3.55
3.2
3.7
%
57.7
58.5
0.27
102
693
(3002179) Metamyelocytes/100 leukocytes in Blood
358
2940
1.24
3.52
3.0
3.8
%
0.8
0.6
0.53
95
694
(1761868) Lipid panel - Serum or Plasma
876
9813
0.87
3.51
3.1
3.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
503
4280
1.20
3.46
3.2
3.0
ng/l
244.1
243.8
0.00
462
3924
(40761536) Microorganisms panel - Urine sediment
374
3093
1.23
3.45
4.3
4.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
259
2057
1.27
3.41
2.2
2.5
%
0.7
0.7
0.21
253
1962
(3043410) Blood group antigens tested for on Red Blood Cells
25
113
2.22
3.41
1.7
2.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
62
381
1.64
3.37
1.7
2.1
u/field
3.9
1.8
1.20
23
134
(3030981) Hyaline casts [#/volume] in Urine by Automated count
291
2349
1.25
3.35
3.1
2.9
e6/l
0.3
0.3
0.04
286
2307
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
62
980
0.63
3.35
1.5
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
283
3490
0.80
3.34
1.3
1.3
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
29
141
2.06
3.31
1.6
2.2
e6/l
18749.0
6032.5
0.30
23
104
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
40
702
0.57
3.28
1.5
1.4
e6/l
356.4
1003.1
1.20
33
572
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
40
702
0.57
3.28
1.4
1.3
e6/l
14.6
24.3
0.32
34
539
(40767503) Oxygen content in Capillary blood by calculation
133
968
1.39
3.23
2.2
2.5
%
15.6
15.9
0.31
69
504
(3025159) Blasts/100 leukocytes in Blood
346
2866
1.22
3.16
3.2
4.0
%
0.1
0.4
1.27
110
756
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
256
3166
0.80
3.11
1.5
1.5
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
12
39
3.08
3.08
1.0
1.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
140
1036
1.36
3.08
2.6
2.9
kpa
8.0
7.8
0.33
130
955
(3008898) HLA-B27 [Presence]
41
701
0.58
3.08
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
335
2775
1.22
3.07
1.3
1.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
10
29
3.45
3.04
1.0
1.0
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
13
45
2.89
3.02
1.4
1.2
ug/l
41.6
115.5
—
8
27
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
26
126
2.07
3.02
1.7
2.0
e6/l
17365.4
22448.4
0.10
20
76
(3004809) Band form neutrophils/100 leukocytes in Blood
103
729
1.42
2.96
2.4
3.8
%
1.5
1.6
0.09
80
546
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
223
0.36
2.91
1.3
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
115
1567
0.73
2.90
1.8
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2813
26997
1.11
2.88
3.9
4.2
mm/h
18.4
14.3
21.80
2524
24598
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
577
5059
1.16
2.79
1.8
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
148
1131
1.32
2.68
1.5
1.6
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
193
1528
1.27
2.68
1.9
2.2
ug/l
392.4
669.1
1.04
187
1442
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
336
2827
1.20
2.66
1.7
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
88
620
1.43
2.63
2.4
2.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
121
900
1.35
2.63
1.3
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3159
32541
0.91
2.44
3.9
4.2
mmol/l
1.3
1.3
3.41
2776
28828
(3006184) Hemoglobin [Mass/volume] in Capillary blood
132
1008
1.32
2.43
1.9
2.3
g/l
121.7
127.2
1.46
97
736
(21494755) Public health laboratory ask at order entry panel
89
1223
0.72
2.42
1.3
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
110
821
1.35
2.37
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
358
4166
0.85
2.37
1.3
1.3
titre
474.9
517.2
0.18
86
933
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
32
183
1.75
2.35
1.2
1.6
u/l
4.3
119.2
—
7
68
(3044007) Cell count panel - Peritoneal fluid
22
111
1.99
2.35
2.0
2.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
91
661
1.38
2.33
3.0
3.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
128
980
1.31
2.33
1.3
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
112
841
1.34
2.33
1.6
1.6
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
27
147
1.84
2.32
1.1
1.3
ug/l
1380.1
351.9
0.56
15
77
(3015171) Extractable nuclear Ab [Units/volume] in Serum
86
1178
0.72
2.31
1.2
1.2
u/ml
0.2
1.0
—
9
115
(3026692) Albumin [Mass/volume] in Peritoneal fluid
21
105
2.00
2.30
1.0
1.5
g/l
15.4
14.5
0.24
21
80
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3408
34941
0.91
2.28
4.9
5.4
mmol/l
2.5
2.6
2.00
3024
31388
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
59
397
1.49
2.28
1.1
1.2
u/l
88.6
58.0
0.81
36
266
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
5
157
0.32
2.26
1.2
1.2
—
62.0
—
0
21
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
318
2709
1.19
2.24
3.5
3.6
mmol/l
1.8
1.9
0.29
227
1976
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
272
0.44
2.23
1.1
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
27
150
1.80
2.19
2.1
3.6
%
53.7
55.0
0.12
27
143
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
35
210
1.67
2.19
1.5
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
35
210
1.67
2.19
1.5
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
35
210
1.67
2.19
1.5
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
35
210
1.67
2.19
1.5
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
328
2810
1.18
2.17
3.5
3.7
ph
7.4
7.4
0.20
45
345
(3021901) Oxygen saturation in Capillary blood
117
895
1.32
2.17
2.5
2.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
122
939
1.31
2.16
1.3
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
332
2849
1.18
2.15
3.6
3.7
kpa
5.1
5.2
1.37
309
2607
(1761482) Bacteria [#/volume] in Urine by Culture
159
1272
1.26
2.09
4.8
4.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
51
340
1.51
2.08
1.2
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
56
0.00
2.06
0.0
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
56
382
1.47
2.05
1.7
2.0
—
1.1
—
0
15
(3029634) Reagin Ab [Titer] in Serum by VDRL
19
354
0.53
2.04
1.4
1.8
—
3.6
—
0
5
(3022493) Free Hemoglobin [Mass/volume] in Plasma
28
162
1.73
2.01
1.2
5.0
mg/l
55.7
68.8
0.57
15
114
(3041096) Erythrocytes [Presence] in Urine by Automated
1004
9295
1.10
2.01
4.2
3.8
—
—
—
0
0
(4034850)
92
1214
0.75
1.98
14.9
11.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
132
1661
0.79
1.97
1.3
1.3
u/ml
168.9
223.4
1.05
119
1512
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
38
241
1.58
1.95
1.4
1.6
u/l
3.3
7.5
1.47
16
112
(3038177) Helicobacter pylori Ab [Presence] in Serum
59
412
1.44
1.94
1.3
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
25
142
1.76
1.92
2.8
2.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
84
626
1.35
1.90
1.8
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
625
5663
1.12
1.88
1.5
1.5
g/l
2.6
2.7
0.38
350
3215
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
17
318
0.53
1.87
1.4
1.6
—
1216.0
—
0
10
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
58
407
1.43
1.87
1.3
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
44
648
0.68
1.85
1.3
1.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
30
182
1.65
1.84
1.9
2.5
ml
1672.0
1862.8
0.56
30
150
(3009261) Glucose [Presence] in Urine by Test strip
1913
18271
1.08
1.84
4.2
4.1
estimate
0.0
0.0
1.08
414
3242
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
263
0.49
1.83
1.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1065
9930
1.09
1.83
4.5
4.5
estimate
0.0
0.0
0.34
377
3154
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
55
384
1.44
1.82
1.3
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
747
8126
0.90
1.79
4.6
4.6
kg/l
1.0
1.0
0.07
128
1284
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3374
34486
0.92
1.77
4.9
5.1
mmol/l
6.2
6.1
2.05
2989
30629
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
53
746
0.71
1.75
1.5
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
18
323
0.56
1.74
1.1
1.1
—
1.6
—
0
7
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
96
743
1.30
1.70
1.1
1.1
u/ml
9.2
9.0
—
6
54
(1002224) Polysomnography panel
65
879
0.74
1.69
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
189
1584
1.20
1.67
2.4
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
23
134
1.72
1.65
4.8
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
23
134
1.72
1.65
4.8
2.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
33
212
1.56
1.64
2.4
3.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2531
26120
0.93
1.64
3.6
3.9
pmol/l
15.0
15.1
0.23
2219
23143
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
27
165
1.64
1.64
1.6
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
27
165
1.64
1.64
1.6
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
59
804
0.73
1.63
1.4
1.6
mg/l
3.3
3.5
0.06
49
590
(3052592) Norovirus Ag [Presence] in Stool
18
98
1.84
1.61
1.3
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
31
474
0.65
1.60
4.4
4.1
umol/l
336.5
342.4
0.09
26
406
(3003181) Sodium [Moles/volume] in Urine
101
795
1.28
1.59
1.3
1.3
mmol/l
51.2
61.9
2.21
69
638
(40761539) Cells [Type] in Urine sediment by Light microscopy
19
106
1.80
1.58
1.2
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
27
167
1.62
1.58
1.6
1.6
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
30
191
1.57
1.56
1.1
1.1
u/l
80.6
87.7
0.18
24
140
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
30
192
1.57
1.53
1.1
1.1
u/l
33.9
33.4
0.01
23
138
(3000570) Elastase.pancreatic [Mass/mass] in Stool
141
1160
1.22
1.52
1.4
1.5
ug/g
237.1
265.0
0.88
91
701
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
5
15
3.34
1.52
1.0
1.1
nmol/l
196.6
265.7
—
5
15
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
43
0.00
1.52
0.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
144
0.42
1.51
1.2
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
55
400
1.38
1.50
1.2
1.2
nmol/l
312.0
325.5
0.17
43
316
(3045683) HLA typing for celiac disease panel - Blood or Tissue
21
123
1.71
1.50
1.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
42
291
1.45
1.50
3.2
3.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
73
557
1.32
1.47
1.3
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
82
636
1.29
1.47
1.2
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1876
18020
1.07
1.46
5.6
5.4
estimate
0.0
0.0
0.50
418
3327
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1197
12638
0.93
1.44
2.1
2.2
u/l
252.0
212.7
0.66
1131
11748
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
18
303
0.59
1.43
1.1
1.1
—
20.3
—
0
6
(3004451) EKG impression Narrative
34
229
1.49
1.41
1.3
1.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
10
46
2.18
1.39
2.9
2.7
u/field
1.0
0.5
—
10
46
(3037556) Urate [Mass/volume] in Serum or Plasma
6
139
0.43
1.39
1.2
1.4
—
—
—
0
0
(4010399)
232
2663
0.86
1.39
1.5
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
321
2854
1.13
1.37
1.5
1.7
%
1.5
1.6
0.49
269
2387
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
6
23
2.61
1.36
1.0
1.0
u/field
1.0
1.0
—
6
15
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
197
1695
1.17
1.34
4.0
4.0
mmol/l
24.6
24.8
0.27
177
1530
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
33
224
1.48
1.33
1.9
1.8
u/field
2.9
2.3
0.18
24
157
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
24
2.50
1.30
1.0
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
427
0.68
1.30
1.1
1.2
miu/ml
99.1
204.1
—
10
141
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
91
729
1.25
1.29
1.3
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
141
1183
1.20
1.29
3.0
3.2
nmol/l
0.9
0.8
0.22
106
891
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
105
1282
0.81
1.29
1.2
1.2
—
—
—
0
0
(44813793)
9
172
0.52
1.29
1.1
1.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1868
18003
1.06
1.27
4.1
4.0
estimate
0.0
0.0
0.00
411
3320
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
48
354
1.36
1.25
1.4
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
48
354
1.36
1.25
1.4
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
48
354
1.36
1.25
1.4
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
63
1.91
1.22
1.1
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
52
390
1.34
1.22
3.6
3.2
mg/l
70.4
36.2
0.33
39
298
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1582
15195
1.06
1.19
2.2
2.2
nmol/l
76.4
79.4
4.30
1410
13228
(3028300) Cannabinoids [Presence] in Urine
17
275
0.62
1.19
1.1
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
167
0.54
1.18
1.3
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
229
2016
1.14
1.17
3.7
3.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
111
921
1.21
1.17
1.9
2.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
105
1266
0.83
1.17
2.8
2.4
g/l
0.0
0.0
0.00
94
1155
(3006462) Nitrate [Presence] in Urine
29
198
1.47
1.16
4.6
3.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
273
0.62
1.16
1.1
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
273
0.62
1.16
1.1
1.5
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
2.1
—
1.2
—
0
20
(3047189) Immunofixation for 24 hour Urine
14
235
0.59
1.14
1.2
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
221
1948
1.14
1.12
2.9
2.8
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
26
175
1.49
1.12
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
26
175
1.49
1.12
1.1
1.0
—
—
—
0
0
(3000492) Spirometry study
254
2845
0.89
1.10
1.4
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
33
234
1.41
1.10
1.3
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
33
234
1.41
1.10
1.3
1.5
—
—
—
0
0
(44790048)
54
415
1.30
1.10
1.2
1.4
—
—
—
0
0
(44806118)
54
415
1.30
1.10
1.2
1.4
—
—
—
0
0
(44790047)
54
415
1.30
1.10
1.2
1.4
—
—
—
0
0
(44790049)
54
415
1.30
1.10
1.2
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
17
267
0.64
1.07
1.1
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
27
186
1.45
1.05
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
33
453
0.73
1.04
1.4
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
453
4178
1.09
1.04
2.4
2.4
ug/l
4.7
7.0
2.61
382
3552
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
216
0.60
1.04
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
216
0.60
1.04
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
216
0.60
1.04
1.0
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3139
31950
0.95
1.04
4.4
4.8
mu/l
3.1
2.1
0.65
2758
28452
(3017446) Testosterone [Moles/volume] in Serum or Plasma
226
2537
0.89
1.03
2.1
2.1
nmol/l
10.0
11.9
2.94
195
2166
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
202
0.59
1.01
1.2
1.3
—
—
—
0
0
(4211845)
30
213
1.41
1.01
4.5
3.8
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
177
0.56
1.01
1.2
1.5
g/l
0.8
0.9
—
10
177
(3048689) Calprotectin [Mass/mass] in Stool
374
3425
1.10
1.01
1.8
2.1
ug/g
272.3
169.9
3.05
283
2638
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
213
0.61
0.99
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
213
0.61
0.99
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
213
0.61
0.99
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
34
248
1.37
0.99
1.2
1.4
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
7
133
0.53
0.98
1.6
1.3
g/l
—
0.2
—
0
11
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
29
0.00
0.97
0.0
2.0
—
17.0
—
0
29
(3016879) Cocaine [Presence] in Urine
17
260
0.65
0.97
1.1
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
87
1044
0.83
0.96
1.6
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1296
12447
1.06
0.96
3.3
3.2
mg/l
193.2
295.7
0.66
879
7947
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
119
0.50
0.93
1.3
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
26
183
1.42
0.93
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
144
1651
0.87
0.93
1.1
1.2
iu/ml
83.2
131.2
1.61
39
562
(3011288) Drugs identified in Urine by Screen method
10
171
0.58
0.91
1.1
1.9
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
26
361
0.72
0.91
1.2
1.2
mmol/l
7.5
7.8
0.15
21
255
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
29
210
1.38
0.90
1.3
1.5
%
62.3
66.8
0.28
23
167
(44816559) Phosphatidylethanol [Mass/volume] in Blood
37
485
0.76
0.89
1.1
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
78
646
1.21
0.89
1.4
1.5
e6/l
1147.6
1845.0
1.96
60
470
(3042111) Morphology [Interpretation] in Bone marrow Narrative
66
805
0.82
0.88
1.4
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
84
702
1.20
0.88
1.5
1.4
nmol/l
0.8
0.8
0.29
73
569
(3020682) Albumin/Creatinine [Ratio] in Urine
1365
13163
1.05
0.87
4.1
4.0
mg/mmol
11.4
9.6
0.57
904
8367
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
21
144
1.46
0.87
1.3
2.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
46
583
0.79
0.87
1.8
1.7
—
—
—
0
0
(4094501)
81
966
0.84
0.86
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
80
955
0.83
0.86
1.3
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
111
1288
0.86
0.86
2.7
2.4
g/l
0.0
0.0
0.66
94
1158
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
31
1.94
0.84
1.0
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
45
1.78
0.84
1.9
1.8
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
44
345
1.28
0.82
2.2
2.1
ml
793.7
635.2
0.90
24
204
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
45
354
1.27
0.82
1.1
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
228
2517
0.90
0.82
2.7
2.7
g/l
10.1
10.7
0.84
202
2276
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
57
697
0.82
0.80
1.2
1.2
—
0.6
—
0
7
(3015235) Bicarbonate [Moles/volume] in Capillary blood
138
1213
1.14
0.80
2.7
3.1
mmol/l
23.9
25.0
2.29
120
1049
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
17
114
1.49
0.79
2.2
2.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
25
182
1.38
0.77
5.7
6.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
5
99
0.50
0.77
44.2
29.8
ug/l
6.3
7.2
—
5
85
(3026493) Urate [Moles/volume] in Serum or Plasma
995
10363
0.95
0.77
2.9
2.9
umol/l
3936.7
5967.9
0.96
864
8707
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
125
0.56
0.77
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
100
0.50
0.77
1.2
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
100
0.50
0.77
1.8
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
56
457
1.23
0.77
2.6
3.7
%
63.7
58.5
0.73
31
280
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
6
34
1.77
0.76
6.5
4.6
ug/min
47.3
60.4
—
6
28
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
6
34
1.77
0.76
1.2
1.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
30
226
1.33
0.76
1.1
1.2
u/l
66.5
24.3
0.97
23
187
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
867
9057
0.95
0.75
3.2
3.3
ug/l
0.8
0.8
0.04
617
6509
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
24
175
1.37
0.74
1.1
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
68
569
1.20
0.74
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
66
551
1.20
0.73
1.4
1.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
62
743
0.83
0.73
1.3
1.2
u/l
35.7
45.8
0.51
56
638
(3035637) Corticotropin [Mass/volume] in Plasma
52
424
1.23
0.73
1.7
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
57
470
1.22
0.72
1.2
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1418
13750
1.05
0.71
4.6
4.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
19
264
0.72
0.71
14.3
14.5
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
26
1.92
0.70
2.8
3.7
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
41
1.71
0.70
1.4
1.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
73
857
0.85
0.69
1.2
1.2
u/ml
50.0
44.1
—
5
48
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
9
144
0.62
0.69
1.1
1.1
—
560.9
—
0
40
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
17
118
1.44
0.69
2.3
1.3
umol/l
26.2
28.9
0.46
17
113
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
129
1452
0.89
0.69
2.7
2.2
g/l
36.1
37.2
1.07
98
1222
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
31
239
1.30
0.69
1.1
1.2
u/l
146.0
93.8
0.82
24
203
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
42
1.67
0.68
2.3
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
117
0.60
0.67
1.0
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1303
12630
1.04
0.67
3.3
3.2
mmol/l
7.4
7.2
1.14
1083
10407
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
69
585
1.18
0.67
2.1
2.2
mg/l
18.9
24.8
0.62
15
134
(3028308) Erythrocytes [#/volume] in Pleural fluid
69
586
1.18
0.66
1.4
1.4
e6/l
229207.2
76405.7
0.68
41
351
(3008116) Ketones [Moles/volume] in Urine by Test strip
13
86
1.51
0.66
1.0
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
22
294
0.75
0.65
1.6
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
69
809
0.85
0.65
1.2
1.2
u/ml
2.5
6.4
1.61
16
140
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
68
798
0.85
0.65
1.2
1.2
u/ml
6.5
3.1
0.62
11
83
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
23
171
1.35
0.65
1.4
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
81
935
0.86
0.64
1.2
1.5
g/l
1.2
1.2
0.18
76
879
(3003434) Protein [Mass/volume] in Pleural fluid
85
737
1.16
0.63
1.3
1.5
g/l
30.8
31.0
0.05
79
659
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
141
1569
0.90
0.63
2.5
2.5
g/l
1.0
1.1
0.12
114
1327
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
38
305
1.25
0.63
1.0
1.1
u/ml
8.9
2.2
0.40
13
92
(3017732) Neutrophils [#/volume] in Blood
254
2349
1.09
0.62
4.0
3.3
e9/l
3.8
4.2
1.94
186
1672
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
8
49
1.63
0.62
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
104
0.58
0.61
2.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
74
857
0.86
0.61
1.3
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
306
3277
0.93
0.61
2.4
2.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
38
307
1.24
0.60
1.3
1.5
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
15
105
1.43
0.60
1.1
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
81
929
0.87
0.60
1.5
1.6
iu/ml
5.8
15.1
0.47
21
216
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
8
52
1.54
0.59
1.1
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
25
322
0.78
0.59
1.4
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
245
2272
1.08
0.58
4.7
3.8
—
—
—
0
0
(3034426) Prothrombin time (PT)
13
89
1.46
0.58
1.0
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
(4146454)
58
493
1.18
0.57
2.5
2.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
518
4932
1.06
0.57
4.3
4.9
%
33.1
33.3
0.14
328
3170
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
36
441
0.81
0.57
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
22
286
0.77
0.56
1.1
1.1
u/ml
0.7
1.7
—
6
100
(46235355) HIV 1 and 2 tests - Meaningful Use set
304
3243
0.93
0.56
1.3
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
96
1082
0.88
0.56
1.2
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
124
1376
0.90
0.55
2.6
2.3
g/l
0.3
0.1
0.38
107
1241
(3036481) Cortisol [Moles/volume] in Serum or Plasma
334
3140
1.07
0.55
2.6
2.2
nmol/l
401.8
375.3
1.43
310
2832
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
37
1.62
0.55
2.7
2.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
50
590
0.85
0.54
1.1
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
125
0.64
0.54
1.0
1.5
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
182
0.71
0.54
1.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
12
170
0.71
0.53
1.2
1.2
mmol/l
6.5
6.2
0.55
12
160
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
39
1.54
0.53
8.5
4.7
—
—
—
0
0
(4133840)
10
66
1.52
0.52
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
96
0.62
0.52
1.3
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
96
0.62
0.52
1.0
1.1
miu/ml
2171.2
1665.3
—
6
96
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
49
415
1.18
0.52
1.4
1.3
nmol/l
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
12
169
0.71
0.51
1.3
1.4
pmol/l
103.5
60.4
—
5
63
(3006245) CD3-CD19+ cells/100 cells in Blood
6
99
0.61
0.51
1.2
2.0
%
29.0
10.6
—
6
85
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
51
434
1.18
0.51
1.3
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
77
677
1.14
0.51
4.0
4.7
iu/ml
442.0
2880.8
—
9
98
(36660697) Celiac disease serology panel - Serum
246
2300
1.07
0.49
1.2
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
17
127
1.34
0.49
2.1
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
53
615
0.86
0.48
1.4
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
107
1185
0.90
0.48
2.5
3.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
56
646
0.87
0.48
1.4
1.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
22
172
1.28
0.48
1.5
1.5
%
6.0
2.7
0.40
17
142
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
29
235
1.24
0.48
2.5
2.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
161
1745
0.92
0.47
2.4
2.4
g/l
9.9
10.3
0.40
127
1461
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
85
950
0.89
0.46
1.3
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
83
0.60
0.45
1.2
1.5
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
8
120
0.67
0.45
1.5
1.9
mmol/l
0.3
1.0
—
8
110
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
141
1532
0.92
0.44
2.7
3.2
ratio
1.5
3.4
—
8
113
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
242
0.78
0.44
1.0
1.1
u/ml
0.4
1.6
—
7
88
(3035880) pH of Pleural fluid
36
302
1.19
0.44
1.2
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
59
672
0.88
0.43
1.1
1.2
u/ml
3.4
6.1
—
6
52
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
230
0.78
0.43
2.2
2.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
84
935
0.90
0.43
2.5
2.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
20
157
1.28
0.43
1.0
1.1
u/ml
2.2
2.1
—
5
60
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
104
945
1.10
0.42
2.7
2.7
mg/l
1.9
1.7
1.26
91
834
(40768443) Skin Pathology biopsy report
161
1734
0.93
0.42
1.2
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
87
1.38
0.42
1.6
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
65
575
1.13
0.42
1.2
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
95
0.63
0.42
1.2
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
139
0.72
0.41
1.1
1.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
30
249
1.21
0.41
5.5
4.9
u/ml
41.0
39.6
—
8
64
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
3.2
—
0
16
(3009214) Lutropin [Units/volume] in Serum or Plasma
55
482
1.14
0.41
1.3
1.3
u/l
16.5
10.3
1.77
47
386
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
106
967
1.10
0.41
1.5
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
36
423
0.85
0.40
1.1
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
60
1.33
0.40
1.0
1.5
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
60
677
0.88
0.40
1.1
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
54
474
1.14
0.40
1.4
1.3
nmol/l
0.6
0.7
0.41
48
449
(3034860) Kappa light chains.free [Mass/volume] in Serum
146
1573
0.93
0.39
2.7
3.3
mg/l
68.4
98.7
0.38
124
1296
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
13
97
1.34
0.39
1.1
1.5
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.3
—
19.6
—
0
12
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
17
215
0.79
0.39
1.2
1.1
nmol/l
0.8
7.7
—
6
50
(3044927) Protein electrophoresis panel - Urine
58
513
1.13
0.38
1.3
1.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
19
151
1.26
0.38
5.4
7.2
mmol/l
25.4
24.5
0.36
14
136
(3033923) Metanephrine [Moles/time] in 24 hour Urine
11
80
1.38
0.38
1.1
1.2
umol/24h
0.7
0.7
—
5
39
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1252
12784
0.97
0.38
4.5
4.7
%
22.6
22.1
0.67
673
6790
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
146
1570
0.93
0.38
2.7
3.3
mg/l
43.8
60.0
0.89
124
1297
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
159
0.75
0.38
1.3
1.1
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
5
36
1.39
0.38
3.6
2.3
—
32.9
—
0
6
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
64
716
0.89
0.38
1.7
1.7
iu/l
9.1
4.3
0.75
18
213
(40761535) Cells panel - Urine sediment
336
3516
0.95
0.37
3.9
3.7
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
37
1.35
0.37
10.6
11.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
91
997
0.91
0.37
1.7
1.6
e6/l
20118.7
14904.0
0.50
69
705
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
224
0.80
0.36
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
41
471
0.87
0.36
1.1
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
49
431
1.14
0.36
1.1
1.3
pmol/l
290.1
273.6
0.16
37
325
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
64
573
1.12
0.36
1.2
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
168
0.77
0.35
1.2
1.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
54
479
1.13
0.35
1.8
1.5
%
70.1
62.4
0.82
37
304
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
56
498
1.13
0.35
1.1
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
33
282
1.17
0.35
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
54
480
1.13
0.34
2.8
4.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
374
3893
0.96
0.34
2.5
2.5
g/l
65.1
66.0
1.10
329
3481
(3045142) Bone marrow Pathology biopsy report
43
489
0.88
0.34
1.2
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
45
1.33
0.33
1.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
14
109
1.29
0.33
1.9
1.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
30
256
1.17
0.33
2.2
2.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
88
0.68
0.33
7.0
8.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
44
498
0.88
0.32
1.1
1.4
u/ml
120.5
117.3
—
10
106
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
39
341
1.14
0.32
1.2
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
47
1.28
0.32
1.0
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
51
570
0.89
0.31
1.1
1.3
—
17.3
—
0
12
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
7
99
0.71
0.30
1.1
2.0
%
20.0
29.6
—
7
89
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
54
1.30
0.30
1.1
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
54
1.30
0.30
1.7
2.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
36
410
0.88
0.30
1.1
1.3
mosm/kgh2o
271.6
276.1
0.80
29
300
(3017569) Oxygen content in Arterial blood
28
240
1.17
0.30
2.3
2.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
114
1063
1.07
0.30
2.2
2.3
ug/min
116.0
93.1
0.20
66
622
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
55
1.27
0.30
1.7
2.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
75
687
1.09
0.29
1.2
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
69
630
1.10
0.29
2.2
2.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
64
702
0.91
0.29
1.1
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
61
554
1.10
0.29
1.3
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
46
412
1.12
0.28
1.2
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
20
237
0.84
0.27
1.9
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
119
0.76
0.27
1.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
95
886
1.07
0.26
1.7
1.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
21
246
0.85
0.26
1.0
1.0
u/ml
0.5
3.0
—
9
101
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
44
396
1.11
0.25
1.2
1.3
u/l
11.2
12.9
0.49
39
357
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
192
0.83
0.25
1.4
1.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
75
1.20
0.25
1.4
1.5
ng/l
186.6
144.3
—
9
75
(3015183) Erythrocyte sedimentation rate
12
96
1.25
0.24
1.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
36
321
1.12
0.24
1.4
1.7
%
11.2
10.7
0.26
36
321
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
45
407
1.11
0.24
1.1
1.2
u/ml
1.9
5.3
3.50
21
180
(3008536) Aspergillus sp Ab [Presence] in Serum
9
77
1.17
0.24
1.2
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
55
503
1.09
0.24
1.5
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
81
0.74
0.24
2.0
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
82
0.73
0.24
1.0
1.0
—
—
—
0
0
(4268621)
31
274
1.13
0.24
2.1
2.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
23
265
0.87
0.24
1.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
16
190
0.84
0.23
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
39
1.28
0.23
1.4
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
168
0.83
0.22
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
189
0.85
0.22
1.4
1.3
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
33
295
1.12
0.22
1.1
1.2
%
96.9
93.9
0.38
28
273
(3018133) Calcium [Moles/volume] in Urine
5
41
1.22
0.22
1.2
1.6
mmol/l
1.8
3.2
—
5
34
(3051387) C reactive protein [Mass/volume] in Capillary blood
86
916
0.94
0.21
3.7
3.8
mg/l
30.5
31.0
0.04
53
600
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
124
0.81
0.21
1.2
1.2
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.7
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
103
0.78
0.21
1.0
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
8
104
0.77
0.21
1.0
1.1
—
11.3
—
0
12
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
43
1.16
0.21
1.2
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
12
145
0.83
0.21
1.3
1.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
13
0.00
0.21
0.0
1.2
—
7.8
—
0
13
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
67
624
1.07
0.20
1.3
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
62
667
0.93
0.20
1.2
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
40
364
1.10
0.20
1.3
1.6
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
18
208
0.86
0.20
1.4
1.9
e6/l
400.1
602.9
—
8
89
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
45
490
0.92
0.20
1.2
1.1
iu/ml
18182.7
53.6
—
10
93
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
122
0.82
0.19
1.4
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
53
1.13
0.18
2.3
1.5
umol/l
37.0
45.5
—
6
53
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
46
424
1.09
0.18
1.2
1.2
u/ml
4.9
3.6
0.18
21
130
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
28
252
1.11
0.17
1.2
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
179
1855
0.96
0.17
2.3
2.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
176
1.14
0.17
1.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
192
1985
0.97
0.17
2.2
1.8
g/l
1.6
1.4
0.11
171
1777
(3011335) Digoxin [Mass/volume] in Serum or Plasma
7
63
1.11
0.17
2.9
2.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
178
1719
1.04
0.17
2.1
2.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
70
0.71
0.16
1.2
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
179
1852
0.97
0.16
2.3
2.4
g/l
3.7
3.8
0.41
117
1311
(3016750) Collection duration of Urine
26
234
1.11
0.16
2.5
2.0
min
500.9
487.8
0.28
17
161
(3023323) Follitropin [Units/volume] in Serum or Plasma
41
443
0.92
0.16
1.2
1.3
iu/l
33.3
34.4
0.08
33
370
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
72
1.11
0.16
1.0
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
51
477
1.07
0.15
4.7
3.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
140
1349
1.04
0.15
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
83
1.21
0.15
1.4
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
9
80
1.13
0.15
1.6
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
69
728
0.95
0.15
1.5
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
46
492
0.93
0.14
1.7
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
180
1856
0.97
0.14
2.3
2.4
g/l
7.8
7.5
1.45
127
1360
(40765096) Chromosome analysis panel by Banding
11
129
0.85
0.14
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1606
15932
1.01
0.14
5.1
5.5
ug/l
3.9
4.2
0.20
1409
14114
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
47
502
0.94
0.14
1.1
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
88
0.80
0.14
1.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
20
223
0.90
0.14
3.5
2.1
mmol/l
10.1
9.3
0.34
11
177
(3011985) Renin [Units/volume] in Plasma
50
469
1.07
0.14
1.2
1.4
mu/l
87.7
64.4
0.27
44
409
(3019420) Tryptase [Mass/volume] in Serum or Plasma
12
139
0.86
0.14
1.3
1.4
ug/l
4.6
9.0
2.49
12
120
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
10
84
1.19
0.14
1.0
1.1
pmol/l
366.2
257.5
—
10
58
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
510
5182
0.98
0.13
11.9
8.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
31
336
0.92
0.13
1.3
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
48
451
1.06
0.13
1.4
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
116
1120
1.04
0.12
1.5
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
70
733
0.95
0.12
1.6
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
104
1.15
0.12
1.1
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
56
531
1.06
0.12
10.2
8.0
mmol/l
6.7
7.6
2.17
50
437
(3048879) Bone marrow aspiration report
15
133
1.13
0.12
1.2
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
95
1.16
0.11
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
24
261
0.92
0.11
1.1
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
76
729
1.04
0.11
1.3
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
14
124
1.13
0.11
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
12
105
1.14
0.11
2.1
2.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
44
465
0.95
0.11
1.1
1.2
u/ml
395.9
298.1
0.79
26
275
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
86
1.16
0.11
1.7
1.3
ug/l
10.6
9.2
—
10
86
(3016650) Hepatitis A virus Ab [Presence] in Serum
49
465
1.05
0.11
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
319
3244
0.98
0.10
1.3
1.3
—
—
—
0
0
(4024509)
47
446
1.05
0.10
1.7
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
45
1.11
0.09
1.6
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
58
556
1.04
0.09
3.6
2.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
327
3318
0.98
0.09
3.6
3.6
ng/l
104.8
96.6
0.79
288
2784
(40758047) Lysozyme [Mass/volume] in Pleural fluid
6
56
1.07
0.08
1.2
1.2
mg/l
4.0
9.3
—
6
50
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
23
247
0.93
0.08
4.0
3.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
171
1745
0.98
0.08
1.2
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
23
214
1.08
0.08
1.0
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
5
63
0.79
0.08
1.2
1.0
umol/l
17.4
16.5
—
5
55
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
185
0.92
0.08
1.1
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
24
224
1.07
0.08
1.2
1.3
promille
1.4
1.1
0.39
16
175
(21494434) Karyotype in Bone marrow
38
399
0.95
0.08
1.1
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
25
266
0.94
0.07
1.4
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
40
382
1.05
0.07
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
876
8819
0.99
0.07
3.7
4.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
76
1.05
0.07
1.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
82
0.85
0.07
2.7
3.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
7
84
0.83
0.07
3.6
6.5
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
8
95
0.84
0.06
7.4
10.5
mmol/l
0.8
0.6
—
8
90
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
24
226
1.06
0.06
2.1
2.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
231
2280
1.01
0.06
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1685
16790
1.01
0.06
2.3
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
61
628
0.97
0.06
1.1
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
286
1.05
0.06
1.4
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
31
296
1.05
0.05
1.1
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
39
375
1.04
0.05
1.1
1.1
%
115.2
113.2
0.16
31
331
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
15
139
1.08
0.05
2.2
1.8
ug/l
61.5
54.5
0.26
15
133
(3035320) C reactive protein [Mass/volume] in Body fluid
28
267
1.05
0.05
2.3
2.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
23
218
1.06
0.05
1.4
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
18
169
1.07
0.05
1.0
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
26
248
1.05
0.05
1.4
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
26
248
1.05
0.05
1.4
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
42
407
1.03
0.04
2.2
2.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
33
318
1.04
0.04
1.2
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
169
1710
0.99
0.04
2.3
2.4
g/l
3.2
3.1
0.92
121
1341
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
116
1177
0.99
0.04
1.1
1.1
u/ml
1.2
1.5
—
6
14
(4306422)
39
378
1.03
0.04
1.2
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
21
200
1.05
0.03
1.3
1.3
u/ml
0.2
1.3
1.28
13
111
(4015189)
12
129
0.93
0.03
2.0
2.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
22
230
0.96
0.03
2.7
2.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
24
250
0.96
0.03
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
24
250
0.96
0.03
1.1
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
38
391
0.97
0.03
1.8
1.3
e6/l
75001.7
126699.5
0.44
26
273
(3006653) Thiamine [Moles/volume] in Blood
18
171
1.05
0.03
1.1
1.2
nmol/l
102.4
137.9
3.19
18
171
(3011412) CD3 cells [#/volume] in Blood
31
300
1.03
0.03
1.8
2.0
e9/l
1.5
1.1
0.34
20
183
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
55
561
0.98
0.03
1.2
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
56
571
0.98
0.02
1.1
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
128
0.94
0.02
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
143
1417
1.01
0.02
1.8
1.7
u/l
39.3
38.1
0.26
126
1199
(3003338) MCHC [Mass/volume]
2783
27805
1.00
0.02
40.2
23.0
g/l
328.6
331.4
41.47
2759
27486
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
26
252
1.03
0.02
1.3
1.5
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
29
282
1.03
0.02
1.2
1.3
g/l
6.7
6.9
0.11
20
200
(3024139) IgG subclass 3 [Mass/volume] in Serum
29
282
1.03
0.02
1.2
1.3
g/l
0.4
0.4
0.10
20
200
(3028192) IgG subclass 2 [Mass/volume] in Serum
29
282
1.03
0.02
1.2
1.3
g/l
3.1
2.9
0.16
20
201
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
103
1.07
0.02
6.3
7.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
31
318
0.97
0.02
1.3
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
338
0.98
0.01
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
127
0.94
0.01
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
19
183
1.04
0.01
1.4
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
23
223
1.03
0.01
1.9
2.0
%
10.7
15.1
—
6
88
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
179
1781
1.01
0.01
3.0
3.1
pmol/l
4.2
4.4
1.40
154
1530
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
36
367
0.98
0.01
1.6
1.5
%
24.1
25.9
0.12
24
231
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
11
104
1.06
0.01
2.4
2.5
mmol/l
6.6
7.7
—
6
61
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
14
146
0.96
0.00
3.4
2.0
umol/l
52.7
53.1
0.02
14
107
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
28
286
0.98
0.00
1.2
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
30
294
1.02
0.00
2.1
2.0
ug/l
1.9
2.0
0.15
25
249
(3024980) IgG subclass 4 [Mass/volume] in Serum
45
456
0.99
0.00
1.6
1.6
g/l
0.7
0.9
0.44
31
348
(4062490)
29
285
1.02
0.00
1.2
1.3
—
—
—
0
0
(3036603) Volume of Urine
26
263
0.99
0.00
1.4
1.7
ml
1815.7
1794.4
—
10
76
(3022621) pH of Urine by Test strip
266
2657
1.00
0.00
3.1
3.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
11
113
0.97
0.00
1.6
1.5
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
105
1.05
0.00
1.1
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
19
188
1.01
0.00
1.2
1.8
—
9.7
—
0
8
(3026389) Candida sp identified in Specimen by Organism specific culture
48
479
1.00
0.00
1.1
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
88
876
1.00
0.00
1.9
1.8
mg/l
11.5
12.8
0.55
82
799
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
23
227
1.01
0.00
1.0
1.2
mmol/l
12.0
12.4
—
10
74
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
96
1.04
0.00
1.1
1.1
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
13
129
1.01
0.00
1.5
2.0
u/l
17.6
59.8
1.38
13
120
(44806420)
16
162
0.99
0.00
2.8
2.4
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
18
178
1.01
0.00
1.5
1.5
%
0.8
3.9
—
5
39
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
114
0.96
0.00
1.5
1.2
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.0
—
17.5
—
0
8
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
64
0.94
0.00
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
409.7
—
0
8
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
8
0.00
0.00
0.0
6.3
—
50.9
—
0
8
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
1468.8
—
0
8
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
3.6
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
56
0.89
0.00
1.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
7
79
0.89
0.00
1.0
1.1
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
91
0.99
0.00
1.0
1.3
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
9
0.00
0.00
0.0
4.9
—
357.4
—
0
9
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
60
1.00
0.00
1.7
1.2
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
91
0.99
0.00
1.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
60
1.00
0.00
1.0
1.1
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
1.4
—
0
6
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
6
0.00
0.00
0.0
8.2
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
96
0.94
0.00
1.1
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
91
0.99
0.00
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
91
0.99
0.00
1.0
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
91
0.99
0.00
1.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
92
0.98
0.00
1.2
2.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
1.5
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_COLON_ADENO – Colon adenocarcinoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).